local_hospital

Clinique Sainte Clotilde

Address
127 Rte de Bois de Nefles, 97400 St Denis, France

Clinique Sainte Clotilde - Gastrointestinal and Head & Neck Cancer Research Center

Clinique Sainte Clotilde is a specialized oncology research center with extensive expertise in gastrointestinal malignancies and head and neck cancers. The center participates in multiple PRODIGE consortium trials, demonstrating a strong commitment to advancing treatment protocols through rigorous phase II and III clinical investigations. Their research portfolio emphasizes personalized cancer care and treatment optimization, particularly focusing on neoadjuvant and adjuvant chemotherapy strategies across diverse oncologic conditions.

  • Gastrointestinal cancers including colon carcinoma, small bowel adenocarcinoma, ampullary adenocarcinoma, and anal squamous cell carcinoma
  • Advanced chemotherapy regimens featuring modified FOLFIRINOX, FOLFOX, and DCF protocols
  • HPV-positive oropharyngeal cancer with focus on treatment de-intensification
  • Hormone-sensitive breast cancer with emphasis on optimizing adjuvant therapy duration

The center's research initiatives include innovative approaches to locally advanced and metastatic cancers, with particular attention to elderly patient populations and risk-stratified treatment strategies. Their participation in trials evaluating both treatment intensification for aggressive disease and de-escalation for low-risk conditions reflects a comprehensive approach to personalized oncology, aiming to maximize efficacy while minimizing treatment-related toxicities and improving quality of life outcomes.

Site Overview

assignment
6
connected trials
corporate_fare
4
sponsors
science
16
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
6
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 3 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
4
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
6
Outperforms 66% of sites
public
Therapeutic diversity
3areas
Outperforms 59% of sites
groups
Sponsor diversity
4sponsors
Outperforms 62% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Clinique Sainte Clotilde

lock Showing 1 of 6 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Neo-Adjuvant Chemotherapy with FOLFOX Regimen in Elderly Patients with Locally Advanced Resectable Colon CarcinomaCentre Hospitalier Universitaire De DijonPhase IIIRecruitingJun 2024

IMP list

lock Showing 1 of 16 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Fluorouracil4Unknown2024-02-092024-09-24

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.